We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Soft Wireless Implant Treats Inflammatory Bowel Disease

By HospiMedica International staff writers
Posted on 19 Jan 2026

Chronic inflammatory diseases such as inflammatory bowel disease (IBD) affect millions worldwide and are often managed with long-term drug therapies that can cause serious side effects. More...

These treatments suppress inflammation broadly rather than correcting the underlying immune imbalance. As a result, flare-ups remain common, and patients face cumulative risks from prolonged medication use. Researchers have now demonstrated a bioelectronic alternative that treats inflammation by precisely modulating immune-controlling nerves.

In the research led by Huazhong University of Science and Technology (HUST, Hubei, China), the team developed a splenic nerve wireless stimulator designed to regulate immune responses through the body’s inflammatory reflex. Unlike conventional neural implants, the entire device, including electrodes, interconnects, and wireless power receivers, is made from a conductive hydrogel engineered to match the softness and flexibility of biological tissue.

The hydrogel-based implant is highly stretchable, electrically conductive, and battery-free, allowing it to operate wirelessly through the skin. Its soft mechanical properties enable intimate contact with delicate nerves while minimizing irritation and fibrosis. The device specifically targets the splenic nerve, a crucial pathway that links the nervous system to immune regulation.

In a rat model of chronic colitis, the implant was placed on the splenic nerve and activated wirelessly for 20 minutes per day. Treated animals showed reduced colon damage, less weight loss, and restoration of normal intestinal structure. The findings, published in National Science Review, demonstrate both therapeutic efficacy and stable device performance.

Further analysis showed that nerve stimulation suppressed pro-inflammatory immune cells while enhancing regulatory and anti-inflammatory cell populations in the gut. After five weeks of implantation, the device remained highly biocompatible with minimal scar tissue formation. The researchers suggest this soft, wireless platform could be adapted to treat other immune-mediated and metabolic diseases by targeting different nerves.

“The biggest challenges for long-term neural interfaces are mechanical mismatch and fibrosis caused by rigid implants,” said Zhiqiang Luo, corresponding author of the study. “Our hydrogel device seamlessly conforms to delicate nerves, operates without batteries, and communicates wirelessly through the skin, which minimizes long-term damage and rejection.”

Related Links:
HUST 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A fluoroscopy image (left) and graphic representation (right) depict a stent graft (yellow arrowhead) being deployed (Photo courtesy of Bruce et al.)

Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery

Coronary artery obstruction is a rare but often fatal complication of heart-valve replacement, particularly in patients with complex anatomy or prior cardiac interventions. In such cases, traditional open-heart... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.